Kamada (KMDA) Tax Provisions (2012 - 2026)
Kamada (KMDA) posted quarterly Tax Provisions of -$1.3 million for Q1 2026, up 52.47% year-on-year from -$825722.0 in Q1 2025, and down 7.42% on a QoQ basis from -$1.2 million in Q4 2025.
Kamada (KMDA) Tax Provisions (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Tax Provisions for 13 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions rose 52.47% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 152.91% YoY) and the FY2025 annual result came in at -$3.3 million, down 389.8% from the prior year.
- Tax Provisions declined to -$1.3 million in Q1 2026 per KMDA's latest filing, from -$1.2 million in the prior quarter.
- Over the last five years, Tax Provisions for KMDA reached as high as $1.3 million in Q4 2024 and fell as low as -$2.6 million in Q1 2025.
- A 5-year average of -$276848.1 and a median of $13.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions soared 729900.0% — and 2024, when it slumped 569330.77%.
- Year by year, Tax Provisions stood at $2000.0 in 2022, then jumped by 1600.0% to $34000.0 in 2023, then jumped by 3867.65% to $1.3 million in 2024, then plunged by 186.88% to -$1.2 million in 2025, then retreated by 7.42% to -$1.3 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$1.3 million, -$1.2 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | 1,623.00 |
| Mar 31, 2025 | -2.65 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -84,000.00 |
| Jun 30, 2024 | -63.00 |
| Mar 31, 2024 | -74,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 13.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 10.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2020 | 281,000.00 |
| Sep 30, 2020 | 348,000.00 |
| Jun 30, 2020 | 390,000.00 |